Skip directly to content


Pfizer has manufacturing plants in Perth (Bentley), Melbourne (Mulgrave) and Adelaide (Thebarton). Our plants manufacture for both the domestic and export markets.

Pfizer employs over 1,000 colleagues across its three manufacturing sites.  

Every single Pfizer product available in Australia – whether made locally or in one of the plants within Pfizer’s extensive manufacturing network – must first pass through a Pfizer Global Supply (PGS) facility.

Every step of the manufacturing process has in place multiple checks and balances to ensure the integrity of the products released to clinicians and their patients.

Every year more than a billion doses of therapeutic goods are manufactured by Pfizer in Australia for distribution within domestic or export markets.

Perth Manufacturing

With its inception in 1969, the Perth manufacturing site is located in Bentley, five kilometers from Perth’s CBD. The site operates 24/7 facility and employs over 500 people.

PGS Perth specialises in aseptic sterile injectable manufacture in unique plastic presentations. The plant utilises Blow Fill Seal (BFS) technology to manufacture hospital products in plastic ampoules (Sterisafe®). The majority of these products are supplied to Australia and New Zealand hospitals. The site also manufactures a range of Oncology products in plastic vials (Cytosafe®). These products are exported globally to markets in North America, Europe, Africa, Latin American, Asia and China. Between all production areas the site manufactures 120 million doses annually.

Melbourne Manufacturing

The Melbourne plant manufactures highly complex biological medicines. Biologics are genetically engineered medicines made from a living organism, such as a virus, gene or protein, to simulate the body’s natural response to infection and disease.

Adelaide Manufacturing

The Adelaide site was established in 2003 and operated as Hospira, until Pfizer and Hospira integrated as a single entity in 2015. 

The site’s major product is pegfilgrastim used to prevent infection in patients undergoing chemotherapy. 

Adelaide’s almost 100 colleagues are employed across chemistry, biology, quality control, manufacturing and compliance and come from a diverse range of backgrounds with 22 nationalities.